chr15-48797527-C-T
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_001194998.2(CEP152):c.314G>A(p.Trp105Ter) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000479 in 1,461,804 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_001194998.2 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CEP152 | NM_001194998.2 | c.314G>A | p.Trp105Ter | stop_gained | 5/27 | ENST00000380950.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CEP152 | ENST00000380950.7 | c.314G>A | p.Trp105Ter | stop_gained | 5/27 | 1 | NM_001194998.2 | A2 | |
CEP152 | ENST00000399334.7 | c.314G>A | p.Trp105Ter | stop_gained | 5/26 | 1 | P2 | ||
CEP152 | ENST00000325747.9 | c.261+134G>A | intron_variant | 1 | A2 | ||||
CEP152 | ENST00000560322.5 | c.314G>A | p.Trp105Ter | stop_gained | 5/13 | 1 |
Frequencies
GnomAD3 genomes AF: 0.00 AC: 0AN: 152130Hom.: 0 Cov.: 32 FAILED QC
GnomAD3 exomes AF: 0.00000401 AC: 1AN: 249364Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135296
GnomAD4 exome AF: 0.00000479 AC: 7AN: 1461804Hom.: 0 Cov.: 32 AF XY: 0.00000413 AC XY: 3AN XY: 727202
GnomAD4 genome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 152130Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74316
ClinVar
Submissions by phenotype
Microcephaly 9, primary, autosomal recessive Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | 3billion | Oct 02, 2021 | Stop-gained (nonsense): predicted to result in a loss or disruption of normal protein function through nonsense-mediated decay (NMD) or protein truncation. Multiple pathogenic variants are reported downstream of the variant (PVS1_VS). It is observed at an extremely low frequency in the gnomAD v2.1.1 dataset (total allele frequency: 0.00000401, PM2). The variant was observed in trans with a pathogenic variant (NM_001194998.1:c.2034T>G) as compound heterozygous (3billion dataset, PM3). Therefore, this variant is classified as pathogenic according to the recommendation of ACMG/AMP guideline. - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Invitae | Dec 10, 2022 | This sequence change creates a premature translational stop signal (p.Trp105*) in the CEP152 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CEP152 are known to be pathogenic (PMID: 21131973). For these reasons, this variant has been classified as Pathogenic. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. ClinVar contains an entry for this variant (Variation ID: 517617). This variant has not been reported in the literature in individuals affected with CEP152-related conditions. This variant is present in population databases (no rsID available, gnomAD 0.006%). - |
Seckel syndrome Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Jan 24, 2018 | The p.Trp105X (NM_001194998.1 c.314G>A) variant in CEP152 has not been previousl y reported in the literature. It has been identified in 1/17238 East Asian chrom osomes by the Genome Aggregation Database (http://gnomad.broadinstitute.org), th ough its frequency is not high enough to rule out a pathogenic role. This nonsen se variant leads to a premature termination codon at position 105, which is pred icted to lead to a truncated or absent protein. Biallelic loss of function of th e CEP152 gene has been associated with Seckel syndrome. In summary, although add itional studies are required to fully establish a null effect, the p.Trp105X var iant is likely pathogenic for Seckel syndrome in an autosomal recessive manner b ased upon its predicted impact on the protein. ACMG/AMP Criteria Applied: PVS1, PM2 (Richards 2015) - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at